PLA2G7 and coronary artery disorder: The conclusions of our study on patients with only chronic ischaemic heart disease lead to a high percentage of increased circulating levels of Lp-PLA2, but also its incidence, which is why we postulate that the enzyme can be supported as a biomarker in chronic ischaemic heart disease.